Brief: Orion, Abilita Therapeutics Announce Research Collaboration

Orion Oyj

18/12/2024 15:02

Dec 18 (Reuters) - Orion Oyj  ORNBV.HE :
    * ORION AND ABILITA THERAPEUTICS ANNOUNCE RESEARCH COLLABORATION AND OPTION TO LICENSE
AGREEMENT
TO DEVELOP INNOVATIVE ANTIBODY THERAPEUTICS
    * GAINS ACCESS TO ABILITA’S ENABLED MEMBRANE PROTEIN TECHNOLOGY
    * COLLABORATION INCLUDES OPTION TO LICENSE ANTIBODY DISCOVERY PROGRAM IN ABILITA’S
PRECLINICAL
PIPELINE WITH POTENTIAL FOR EXPANSION INTO TWO ADDITIONAL PROGRAMS IN FUTURE
    * ABILITA TO RECEIVE ROYALTIES ON COMMERCIAL SALES
    * ABILITA TO RECEIVE UPFRONT, DEVELOPMENT, AND SALES MILESTONE PAYMENTS

Source text:  ID:nGNE3t3LsM 
Further company coverage:  ORNBV.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))